The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

Getting the annual RSV shot and other important vaccines is a fantastic way to safeguard yourself and your family as winter ...

Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

However, even established players have struggled. In its Q3 results, GSK (GSK), the first to receive U.S. approval for an RSV ...

The respiratory virus is the leading cause of hospitalisation for infants, with 12,000 babies admitted each year. Before next ...

Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...

Researchers sought to determine if the RSV vaccine leads to better health outcomes among older adults with IBD.

Executive Summary - Despite the demonstrated effectiveness of prenatal vaccines, uptake remains low. This puts mothers and babies ...

Moderna said its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last iteration of the shot did in 2023.

For adults aged 60 years or older, RSV vaccination is effective for preventing associated hospitalizations and ED encounters.

Australia will fund free RSV vaccines for newborns and pregnant women starting in 2025, aiming to protect vulnerable groups ...